ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Brief Report: Phase I clinical trial of trametinib and ponatinib in patients with non-small cell lung cancer harboring KRAS mutations
JTO Clinical and Research Reports
◽
10.1016/j.jtocrr.2021.100256
◽
2021
◽
pp. 100256
Author(s):
Kathryn C. Arbour
◽
Eusebio Manchado
◽
Matthew J. Bott
◽
Linda Ahn
◽
Yosef Tobi
◽
...
Keyword(s):
Lung Cancer
◽
Clinical Trial
◽
Phase I
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Small Cell
◽
Phase I Clinical Trial
◽
Small Cell Lung
◽
Kras Mutations
Download Full-text
Related Documents
Cited By
References
A phase I clinical trial of weekly oral topotecan for relapsed small cell lung cancer
Cancer Chemotherapy and Pharmacology
◽
10.1007/s00280-013-2167-0
◽
2013
◽
Vol 72
(1)
◽
pp. 45-51
◽
Cited By ~ 4
Author(s):
S. Agelaki
◽
E. Kontopodis
◽
A. Kotsakis
◽
V. Chandrinos
◽
I. Bompolaki
◽
...
Keyword(s):
Lung Cancer
◽
Clinical Trial
◽
Phase I
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Small Cell
◽
Phase I Clinical Trial
◽
Small Cell Lung
◽
Oral Topotecan
Download Full-text
Phase I clinical trial of irinotecan (CPT-11), 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxy-camptothecin, and cisplatin in combination with fixed dose of vindesine in advanced non-small cell lung cancer
Lung Cancer
◽
10.1016/0169-5002(95)96452-2
◽
1995
◽
Vol 12
(1-2)
◽
pp. 153-154
Keyword(s):
Lung Cancer
◽
Clinical Trial
◽
Phase I
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Small Cell
◽
Phase I Clinical Trial
◽
Fixed Dose
◽
Small Cell Lung
Download Full-text
A Phase I Clinical Trial of Irinotecan and Carboplatin in Patients with Extensive Stage Small Cell Lung Cancer
Chemotherapy
◽
10.1159/000341274
◽
2012
◽
Vol 58
(4)
◽
pp. 257-263
◽
Cited By ~ 4
Author(s):
Simon J. Crabb
◽
Jennifer Bradbury
◽
Luke Nolan
◽
Diana Selman
◽
Sethupathi R. Muthuramalingam
◽
...
Keyword(s):
Lung Cancer
◽
Clinical Trial
◽
Phase I
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Small Cell
◽
Phase I Clinical Trial
◽
Small Cell Lung
◽
Extensive Stage
Download Full-text
P-562 Phase I clinical trial with Topotecan, Adriamycin and Vincristine (TAV) in patients with advanced Small (SCLC) and Non-Small Cell Lung Cancer (NSCLC
Lung Cancer
◽
10.1016/s0169-5002(03)92529-3
◽
2003
◽
Vol 41
◽
pp. S233
Author(s):
Swaminathan Padmanabhan
◽
Luis E. Raez
◽
Edgardo Santos
◽
Shou-ching Tang
◽
Juan C. Ramos
◽
...
Keyword(s):
Lung Cancer
◽
Clinical Trial
◽
Phase I
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Small Cell
◽
Phase I Clinical Trial
◽
Small Cell Lung
Download Full-text
A Phase I Clinical Trial of Thoracic Radiotherapy and Concurrent Celecoxib for Patients with Unfavorable Performance Status Inoperable/Unresectable Non–Small Cell Lung Cancer
Clinical Cancer Research
◽
10.1158/1078-0432.ccr-04-1741
◽
2005
◽
Vol 11
(9)
◽
pp. 3342-3348
◽
Cited By ~ 59
Author(s):
Zhongxing Liao
◽
Ritsuko Komaki
◽
Luka Milas
◽
Chen Yuan
◽
Merrill Kies
◽
...
Keyword(s):
Lung Cancer
◽
Clinical Trial
◽
Phase I
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Performance Status
◽
Small Cell
◽
Phase I Clinical Trial
◽
Thoracic Radiotherapy
◽
Small Cell Lung
Download Full-text
Dual EGFR inhibition in combination with anti-VEGF treatment: A phase I clinical trial in non-small cell lung cancer
Oncotarget
◽
10.18632/oncotarget.763
◽
2013
◽
Vol 4
(1)
◽
pp. 118-127
◽
Cited By ~ 25
Author(s):
Gerald S. Falchook
◽
Aung Naing
◽
David S. Hong
◽
Ralph Zinner
◽
Siqing Fu
◽
...
Keyword(s):
Lung Cancer
◽
Clinical Trial
◽
Phase I
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Small Cell
◽
Phase I Clinical Trial
◽
Small Cell Lung
◽
Egfr Inhibition
◽
Anti Vegf
Download Full-text
Template-assisted 192 Ir-based stereotactic ablative brachytherapy as a neoadjuvant treatment for operable peripheral non-small cell lung cancer: a phase I clinical trial
Journal of Contemporary Brachytherapy
◽
10.5114/jcb.2019.84613
◽
2019
◽
Vol 11
(2)
◽
pp. 162-168
Author(s):
Xiang-xiang Shi
◽
Hao-wen Pang
◽
Pei-rong Ren
◽
Xiao-yang Sun
◽
Jing-bo Wu
◽
...
Keyword(s):
Lung Cancer
◽
Clinical Trial
◽
Phase I
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Neoadjuvant Treatment
◽
Small Cell
◽
Phase I Clinical Trial
◽
Small Cell Lung
Download Full-text
Abstract CT198: Expansion of Phase I/II study of olaparib and temozolomide in patients with relapsed small cell lung cancer (SCLC) and co-clinical trial in patient-derived xenografts (PDXs) for biomarker discovery
10.1158/1538-7445.sabcs18-ct198
◽
2019
◽
Author(s):
Anna F. Farago
◽
Beow Yeap
◽
Yin P. Hung
◽
Marcello Stanzione
◽
Jun Zhong
◽
...
Keyword(s):
Lung Cancer
◽
Clinical Trial
◽
Phase I
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Biomarker Discovery
◽
Small Cell
◽
Small Cell Lung
Download Full-text
Phase I/II clinical trial of didemnin B in non-small-cell lung cancer: Neuromuscular toxicity is dose-limiting
Lung Cancer
◽
10.1016/0169-5002(92)90195-p
◽
1992
◽
Vol 8
(2)
◽
pp. 137
Keyword(s):
Lung Cancer
◽
Clinical Trial
◽
Phase I
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Small Cell
◽
Didemnin B
◽
Small Cell Lung
Download Full-text
Preliminary results of an escalating dose phase I clinical trial of the anti-EGFR monoclonal antibody nimotuzumab in combination with external radiotherapy in patients diagnosed with stage IIb, III or IV non-small cell lung cancer unsuitable for radical therapy
Journal of Clinical Oncology
◽
10.1200/jco.2008.26.15_suppl.3037
◽
2008
◽
Vol 26
(15_suppl)
◽
pp. 3037-3037
◽
Cited By ~ 4
Author(s):
D. G. Bebb
◽
A. M. Brade
◽
C. Smith
◽
S. Rorke
◽
I. Sherman
Keyword(s):
Lung Cancer
◽
Clinical Trial
◽
Monoclonal Antibody
◽
Phase I
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Small Cell
◽
External Radiotherapy
◽
Small Cell Lung
◽
Radical Therapy
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close